Free public records show Sichuan Baili Pharmaceutical Co., Ltd. in 14 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Sichuan Baili Pharmaceutical Co., Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
131 active studies led by Sichuan Baili Pharmaceutical Co., Ltd., of 136 in all
Source: ClinicalTrials.gov, Studies with Sichuan Baili Pharmaceutical Co., Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Sichuan Baili Pharmaceutical Co., Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Sichuan Baili Pharmaceutical Co., Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Sichuan Baili Pharmaceutical Co., Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Sichuan Baili Pharmaceutical Co., Ltd. is in.
Stories on the topics Sichuan Baili Pharmaceutical Co., Ltd. works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
ReadSearch all reports for Sichuan Baili Pharmaceutical Co., Ltd. All companies